Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 69 clinical trials
The PROFILE Study: Germline Genetic Profiling: Correlation With Targeted Prostate Cancer Screening and Treatment

Prostate cancer is now the commonest cancer in men in the Western world, with over 49,000 new cases diagnosed each year and a lifetime risk of 1 in 11 in the United Kingdom. Prostate cancer (PrCa) can run in some families and research studies have identified several genetic changes in …

prostate specific antigen
prostate cancer screening
  • 1 views
  • 21 Jun, 2021
  • 1 location
Bariatric Surgery and Pharmacokinetics of Apixaban

study we investigate the pharmacokinetic effects of bariatric surgery on apixaban.

gastrointestinal transit
gastric bypass
bariatric surgery
gastric ph
gastrectomy
  • 23 views
  • 16 Mar, 2021
  • 1 location
Apixaban in Adults With Congenital Heart Disease and Atrial Arrhythmias: the PROTECT-AR Study

The purpose of this study is to evaluate the safety and efficacy of apixaban for the prevention of thromboembolism in adult patients with congenital heart disease (CHD) and non-valvular atrial

arrhythmia
apixaban
thromboembolism
  • 2 views
  • 03 Feb, 2021
  • 8 locations
Monitoring of NOAC Therapy: Standardizing Reference Intervals

This study is aimed to establish reference intervals of NOAC (dabigatran, apixaban and rivaroxaban) in ethnic Chinese patients.

  • 0 views
  • 26 Jan, 2021
  • 1 location
DOAC in Unusual Site Venous Thrombosis

-inhibitors (such as dabigatran, apixaban, edoxaban, rivaroxaban), in patients with unusual VTE in clinical practice is increasing. Through an international multicentre prospective registry, the investigators

thrombin
rivaroxaban
anticoagulants
clot
thromboembolism
  • 0 views
  • 25 Jan, 2021
  • 1 location
Multi-site Study for Evaluation of Clinical Ranges of Whole Blood Clotting Times of Patients on Anticoagulants and Verification of Measurement Precision of Liquid Quality Controls With the Perosphere Technologies' PoC Coagulometer

Technologies' PoC Coagulometer has shown sensitivity to a broad range of drugs and reagents that affect blood clotting processes, including the Direct Oral Anticoagulants, DOACs (e.g. rivaroxaban, apixaban

  • 0 views
  • 07 May, 2021
  • 1 location
Registry of Patient With Antithrombotic Agents Admitted to an Emergency Department

(Apixaban rivaroxaban, dabigatran ...) should profoundly change the management of venous thromboembolism and cardioembolic event. Because of their risk-benefit, simplicity and convenience of their

  • 0 views
  • 21 Jan, 2021
Pilot Study: Comparison of Patients' Knowledge of Direct Oral Anticoagulants Between 2 Cardiology Departments Offering or Not a Pharmaceutical Interview

Direct oral anticoagulants (Rivaroxaban, Apixaban and Dabigatran) are an alternative to anti-vitamin K drugs and low molecular weight heparins in many cardiovascular diseases. This new

anticoagulation therapy
vitamin k
dabigatran
thrombosis
rivaroxaban
  • 0 views
  • 20 May, 2021
  • 2 locations
'Understanding the Electrophysiological Substrate Underlying Persistent Atrial Fibrillation Study II (USURP AF- Study II)'

Atrial fibrillation (AF) is the most common type of chronic heart rhythm disease worldwide, with significant associated co-morbidities. Although there have been advances in understanding the mechanisms of AF, the underlying cause of AF and factors which perpetuate it remain incompletely understood. This is particularly the case for persistent AF …

pulmonary vein isolation
paroxysmal atrial fibrillation
arrhythmia
catheter ablation
ablations
  • 1 views
  • 10 May, 2021
  • 1 location